Literature DB >> 1508681

Evidence for a HeLa cell splicing activity that is necessary for activation of a regulated adenovirus 3' splice site.

K Zerivitz1, J P Kreivi, G Akusjärvi.   

Abstract

Adenovirus late region 1 pre-mRNA splicing is temporally regulated during a lytic infection at the level of alternative 3' splice site usage to produce two mRNAs; the 52,55K and IIIa mRNAs which utilize the proximal and distal 3' splice sites, respectively. In vivo, the 52,55K mRNA is produced both early and late after infection, while IIIa is produced exclusively late in infection. Uninfected HeLa cell nuclear extracts, prepared with a low salt (0.4-0.5 M) or high salt (0.6 M and higher) wash, differed in their ability to splice 52,55K, IIIa and beta-globin transcripts. 52,55K and beta-globin precursors were spliced with similar efficiency in the low and high salt extract, while the IIIa mRNA was generated only in the high salt extract. Using the beta-globin pre-mRNA, no kinetic differences between the two types of extracts were observed. Nor were there any significant differences in the snRNA composition. The IIIa splicing activity did not appear to correlate with U2AF and pPTB levels. Our results suggest that a cellular trans-acting factor(s), which is required for adenovirus IIIa 3' splice site activation, is solubilized only at high salt concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508681      PMCID: PMC334072          DOI: 10.1093/nar/20.15.3955

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  39 in total

1.  Sequences involved in the control of adenovirus L1 alternative RNA splicing.

Authors:  J P Kreivi; K Zerivitz; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 2.  Pre-mRNA splicing in yeast.

Authors:  S W Ruby; J Abelson
Journal:  Trends Genet       Date:  1991-03       Impact factor: 11.639

3.  Control of adenovirus alternative RNA splicing: effect of viral DNA replication on RNA splice site choice.

Authors:  S Larsson; J P Kreivi; G Akusjärvi
Journal:  Gene       Date:  1991-11-15       Impact factor: 3.688

4.  A role for exon sequences and splice-site proximity in splice-site selection.

Authors:  R Reed; T Maniatis
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

5.  Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F.

Authors:  F Rozen; I Edery; K Meerovitch; T E Dever; W C Merrick; N Sonenberg
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  Targeted snRNP depletion reveals an additional role for mammalian U1 snRNP in spliceosome assembly.

Authors:  S M Barabino; B J Blencowe; U Ryder; B S Sproat; A I Lamond
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

7.  Controls of RNA splicing and termination in the major late adenovirus transcription unit.

Authors:  G Akusjärvi; H Persson
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

8.  Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

Authors:  A Mayeda; A R Krainer
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

9.  Three protein factors (SF1, SF3 and U2AF) function in pre-splicing complex formation in addition to snRNPs.

Authors:  A Krämer; U Utans
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  Biochemical characterization of U2 snRNP auxiliary factor: an essential pre-mRNA splicing factor with a novel intranuclear distribution.

Authors:  P D Zamore; M R Green
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  2 in total

1.  Regulation of adenovirus alternative RNA splicing at the level of commitment complex formation.

Authors:  J P Kreivi; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

2.  Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Authors:  A Mayeda; D M Helfman; A R Krainer
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.